about
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxationA pathophysiology-based approach to the management of early priapismMolecular pathophysiology of priapism: emerging targetsUncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17.Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.Physiology of penile erection and pathophysiology of erectile dysfunctionNew approaches to the design and discovery of therapies to prevent erectile dysfunction.RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunctionInvolvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function.A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosumGas what: NO is not the only answer to sexual function.Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis.Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges.Understanding and targeting the Rho kinase pathway in erectile dysfunction.Endothelial dysfunction in diabetic erectile dysfunction.Physiological regulation of penile arteries and veins.Aging impairs Ca2+ sensitization pathways in gallbladder smooth muscle.Caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injury is mediated via RhoA and ROCK activation in major pelvic ganglion.Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell miceHydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle.Smooth muscle cell calcium activation mechanisms.Emerging role for TNF-α in erectile dysfunction.Long-term diabetic complications may be ameliorated by targeting Rho kinase.Hydrogen sulfide and erectile function: a novel therapeutic target.The promise of inhibition of smooth muscle tone as a treatment for erectile dysfunction: where are we now?How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.Nitrergic Mechanisms for Management of Recurrent PriapismPriapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies.Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction?Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.Association of nNOS and Rho-kinase with age-associated erectile dysfunction in Sprague-Dawley rats.Regulation of intracellular Ca2+ release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP.Endothelin-1-induced contraction in veins is independent of hydrogen peroxide.Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens.RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum.Modulation of spontaneous Ca2+-activated Cl- currents in the rabbit corpus cavernosum by the nitric oxide-cGMP pathway.Role of PKCalpha and PKCiota in phenylephrine-induced contraction of rat corpora cavernosa.Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats.Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
P2860
Q24656291-81F9F577-222F-45DB-852F-48F7A033A7D5Q26825268-1584FFA2-4C78-4F9E-9C43-996D921CC62CQ27010069-BD6D6AF3-7CAE-4107-BB95-1C94EE92E6F4Q30435309-41B07CCB-344C-4DF6-96F1-7F302DBE41F9Q33755241-9CB80F0A-2B32-456A-949B-AECC5E282176Q34312991-29578E23-E1ED-47EC-B580-AA8320783CBFQ34664336-8B7BF28C-1A8D-4EB9-9616-8C1C174EC65BQ34836681-66661E8A-2512-4A59-A7F5-104105F927CEQ34983511-C25CB06E-DAC2-4F68-9B4B-B96869E14767Q35001011-BFB57943-05F9-42A9-AA9F-DD0931565424Q35044932-6CFF0F7A-E58F-4C8C-B2E9-C216762ACA72Q35204833-21B58439-6DB7-4196-85C9-DB15FB1AF6D8Q35894523-74855764-A14F-4C79-B126-51571E4139D8Q36219699-DA627F68-BB26-4909-A2A3-98D24F12297EQ36416633-C98B2C11-8003-4DFF-BF6F-9FE93F07D12BQ36507302-9064D041-DAAC-470E-B911-EE2AC539A976Q36885422-B4709F66-3165-4AFC-B629-7F995AA98ECFQ36927508-496EDF0B-DA9E-4A49-9396-6D2DD8F6E86CQ37076569-CBC7944D-EC5F-4C9B-9B04-20761AE16880Q37146167-24F23DBC-6ED7-4063-887C-DE663C682621Q37218153-7A9E89F2-E270-41ED-91BB-F7FD7114FEA9Q37267005-BFB42045-E22C-439D-8591-363B1C4EF100Q37719686-510773E3-C200-4467-B0DB-7408C5DA0186Q37838899-0FB6415E-179B-437C-8E20-378BBBF413CEQ37862060-80597E42-5BE8-4F1C-B7A8-70E565FB23F3Q37942765-F061275A-269C-4E3D-A573-63FD4F1D114BQ38246404-E7BFC32D-D2B0-43BB-94E1-D4112AAF2849Q38610620-64D31530-ADDB-4626-93D2-91C3E8BD367EQ39760861-1EF51809-CE59-4057-AC70-7AE0F4ED5F23Q39813516-D9A84205-8C33-426D-A0D5-4072B4AF3BF6Q41873056-AF4382DF-B06B-4BB2-99F9-4EE691D8ED03Q42290624-7AF1FDE9-65E0-4E13-9264-44EFED5D0785Q42470364-17864CEC-64BF-456F-A63A-E74C60D11DFDQ42478635-2C09883A-5D31-4D72-81AB-90C203C60311Q43263216-A3192A1A-AC67-46B1-A137-A162B4E64E45Q44534215-2E2747D9-EA69-42A4-9127-18F1A0859BDBQ44758490-B5919D2F-D93A-420D-9263-2D8A472585B0Q44762859-59524497-D4F5-4B77-9CF8-7A7C13BD446CQ44837061-A9312988-7D91-4FE5-ADB0-BA712E2E5E23Q45267408-64594641-B3A0-4973-9312-1A526E95512D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
RhoA-mediated Ca2+ sensitization in erectile function.
@ast
RhoA-mediated Ca2+ sensitization in erectile function.
@en
type
label
RhoA-mediated Ca2+ sensitization in erectile function.
@ast
RhoA-mediated Ca2+ sensitization in erectile function.
@en
prefLabel
RhoA-mediated Ca2+ sensitization in erectile function.
@ast
RhoA-mediated Ca2+ sensitization in erectile function.
@en
P2093
P2860
P356
P1476
RhoA-mediated Ca2+ sensitization in erectile function.
@en
P2093
Andrew P Somlyo
Avril V Somlyo
P2860
P304
30614-30621
P356
10.1074/JBC.M204262200
P407
P577
2002-06-11T00:00:00Z